<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Arachidonate epoxygenase / epoxide hydrolase" Organism="Homo sapiens" License="CC BY 2.0">
  <Comment>Fatty Acid Epoxygenase</Comment>
  <Comment>Type your comment here</Comment>
  <Comment Source="WikiPathways-description">The cytochrome P450-dependent formation of polyunsaturated fatty acid epoxides is an important biochemical pathway creating mediators of inflammation and blood pressure regulation.  Once formed these compounds can be incorperated into phospholipid membrance, and released by the action of phospholipase A2.  The epoxides of arachidonic acid, i.e. the epoxyeicosatrieneoic acid or EETs, are putative endothelial derived hyperpolarization factors which increase the open state probability of Ca++ sensitive K+ channels, leading to vasodilation in arteriolar beds.  The 11(12)-EET in particular appears to have potent functions in vasodilation, and are inhibitors of NFKb dependent inflammatory signalling, and PAI-1 activity.  The 5(6)-EET appears unique, in that its metabolic transformation through cyclooxygenase activities produces potent vasoconstrictors.  With the exception of the 5(6)-EET, these epoxy fatty acids are good substrates for the soluble epoxide hydrolase.  Hydrolytic tranformation to vicinal diols eliminates vasoactive actions, however these vicinal diols have been reported to have other biological activites, including PPAR-alpha activation.  Recent development of inhibitors of the soluble epoxide hydrolase are proving to have potent anti-inflammatory, anti-hypertensive, and anti-nociceptive properties.  Reports of enzyme catalyzed glutathione-conjugates of the epoxy fatty acids have been reported, but the activity and relavance of these potential metabolic products are unknown to date.</Comment>
  <Comment Source="WikiPathways-category">Metabolic Process</Comment>
  <BiopaxRef>d99</BiopaxRef>
  <BiopaxRef>f4f</BiopaxRef>
  <BiopaxRef>e20</BiopaxRef>
  <BiopaxRef>f2c</BiopaxRef>
  <BiopaxRef>c93</BiopaxRef>
  <BiopaxRef>f90</BiopaxRef>
  <BiopaxRef>f0e</BiopaxRef>
  <BiopaxRef>e4e</BiopaxRef>
  <BiopaxRef>b10</BiopaxRef>
  <BiopaxRef>e72</BiopaxRef>
  <BiopaxRef>c2d</BiopaxRef>
  <BiopaxRef>cdd</BiopaxRef>
  <BiopaxRef>e66</BiopaxRef>
  <BiopaxRef>e2b</BiopaxRef>
  <Graphics BoardWidth="738.0" BoardHeight="503.0"/>
  <DataNode TextLabel="Glutathionyl-HETrEs" GraphId="a1bc4" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP2C9" GraphId="a8a52" Type="GeneProduct" GroupRef="de461">
    <BiopaxRef>e72</BiopaxRef>
    <BiopaxRef>d1b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5,6-DiH-PGF1a" GraphId="a945f" Type="Metabolite">
    <Comment>full name = 5,6-Dihydro-Prostaglandin F1a</Comment>
    <BiopaxRef>b9c</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="EPHX2" GraphId="aa0ff" Type="GeneProduct">
    <BiopaxRef>f90</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Phosphotidyl-EpETrEs" GraphId="acb71" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="11,12-DiHETrE" GraphId="b5129" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="COX" GraphId="b6681" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="EPHX2" GraphId="badaa" Type="GeneProduct">
    <BiopaxRef>f90</BiopaxRef>
    <BiopaxRef>e4e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="14(15)-EpETrE" GraphId="bc1ef" Type="Metabolite" GroupRef="fe433">
    <BiopaxRef>e2b</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="EPHX2" GraphId="c176d" Type="GeneProduct">
    <BiopaxRef>f90</BiopaxRef>
    <BiopaxRef>e4e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5(6)-Epoxy-PGE1" GraphId="c40e2" Type="Metabolite">
    <BiopaxRef>e2b</BiopaxRef>
    <BiopaxRef>b9c</BiopaxRef>
    <BiopaxRef>d1b</BiopaxRef>
    <BiopaxRef>c86</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP2C8" GraphId="c993a" Type="GeneProduct" GroupRef="de461">
    <BiopaxRef>e72</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5,6-DiHETrE" GraphId="c9b45" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GST3" GraphId="d2df9" Type="GeneProduct">
    <BiopaxRef>dbf</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Catalyst" GraphId="d31e1" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="8(9)-EpETrE" GraphId="d6b43" Type="Metabolite" GroupRef="fe433">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="5(6)-EpETrE" GraphId="d8196" Type="Metabolite" GroupRef="fe433">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="11(12)-EpETrE" GraphId="d8b30" Type="Metabolite" GroupRef="fe433">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="COX" GraphId="d9b22" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CYP2J2" GraphId="de5f5" Type="GeneProduct" GroupRef="de461">
    <BiopaxRef>b10</BiopaxRef>
    <BiopaxRef>e72</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="EPHX2" GraphId="dfe44" Type="GeneProduct">
    <Comment>5(6)-EpETrE is a poor sEH substrate</Comment>
    <Comment>Type your comment here</Comment>
        </DataNode>
  <DataNode TextLabel="8,9-DiHETrE" GraphId="e7065" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="14,15-DiHETrE" GraphId="f01bc" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Arachidonic acid" GraphId="ff9e1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <Interaction GraphId="aa119">
    <Graphics>
      <Point GraphRef="e8f29"/>
      <Point GraphRef="acb71" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="de843"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ade26">
    <Graphics>
      <Point GraphRef="d31e1"/>
      <Point GraphRef="de843" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8708">
    <Graphics>
      <Point GraphRef="dfe44"/>
      <Point GraphRef="a185f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bab8a">
    <Graphics>
      <Point GraphRef="d2df9"/>
      <Point GraphRef="aa96d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c48e6">
    <Graphics>
      <Point GraphRef="d9b22"/>
      <Point GraphRef="fdcfd" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c8864">
    <Graphics>
      <Point GraphRef="bc1ef"/>
      <Point GraphRef="f01bc" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="f8574"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ca8a2">
    <Graphics>
      <Point GraphRef="c9b45"/>
      <Point GraphRef="a945f" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="fdcfd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cba10">
    <Graphics>
      <Point GraphRef="b6681"/>
      <Point GraphRef="c29e9" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cccad">
    <Graphics>
      <Point GraphRef="d8196"/>
      <Point GraphRef="c9b45" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="a185f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0268">
    <Graphics>
      <Point GraphRef="ff9e1"/>
      <Point GraphRef="e8f29" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="f25cc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db474">
    <Graphics>
      <Point GraphRef="d6b43"/>
      <Point GraphRef="e7065" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="fe57f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd8c5">
    <Graphics>
      <Point GraphRef="f25cc" ArrowHead="mim-catalysis"/>
      <Point GraphRef="aa04d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e27d2">
    <Graphics>
      <Point GraphRef="badaa"/>
      <Point GraphRef="f8574" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec492">
    <Graphics>
      <Point GraphRef="aa0ff"/>
      <Point GraphRef="fe57f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="edaa6">
    <Graphics>
      <Point GraphRef="d8b30"/>
      <Point GraphRef="b5129" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="c2265"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0208">
    <Graphics>
      <Point GraphRef="c176d"/>
      <Point GraphRef="c2265" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f4058">
    <Graphics>
      <Point GraphRef="e8f29"/>
      <Point GraphRef="a1bc4" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="aa96d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fc673">
    <Graphics>
      <Point GraphRef="d8196"/>
      <Point GraphRef="c40e2" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="c29e9"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Product" GraphId="b3f6a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Product" GraphId="d9ad3">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Group GroupId="de461" GraphId="aa04d" Style="Group"/>
  <Group GroupId="fe433" GraphId="e8f29" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2b">
      <bp:ID >3977905</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >On the metabolism of epoxyeicosatrienoic acids by ram seminal vesicles: isolation of 5(6)epoxy-prostaglandin F1 alpha.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >Oliw EH</bp:AUTHORS>
      <bp:AUTHORS >Benthin G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e72">
      <bp:ID >16258029</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Heart Circ Physiol</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Larsen BT</bp:AUTHORS>
      <bp:AUTHORS >Miura H</bp:AUTHORS>
      <bp:AUTHORS >Hatoum OA</bp:AUTHORS>
      <bp:AUTHORS >Campbell WB</bp:AUTHORS>
      <bp:AUTHORS >Hammock BD</bp:AUTHORS>
      <bp:AUTHORS >Zeldin DC</bp:AUTHORS>
      <bp:AUTHORS >Falck JR</bp:AUTHORS>
      <bp:AUTHORS >Gutterman DD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d99">
      <bp:ID >14636671</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.</bp:TITLE>
      <bp:SOURCE >Prog Lipid Res</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Spector AA</bp:AUTHORS>
      <bp:AUTHORS >Fang X</bp:AUTHORS>
      <bp:AUTHORS >Snyder GD</bp:AUTHORS>
      <bp:AUTHORS >Weintraub NL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e20">
      <bp:ID >10759591</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular mechanisms controlling nutritive blood flow: role of cytochrome P450 enzymes.</bp:TITLE>
      <bp:SOURCE >Acta Physiol Scand</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Harder DR</bp:AUTHORS>
      <bp:AUTHORS >Roman RJ</bp:AUTHORS>
      <bp:AUTHORS >Gebremedhin D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c86">
      <bp:ID >17494091</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Renal Physiol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >N&#195;&#175;&#194;&#191;&#194;&#189;sing RM</bp:AUTHORS>
      <bp:AUTHORS >Schweer H</bp:AUTHORS>
      <bp:AUTHORS >Fleming I</bp:AUTHORS>
      <bp:AUTHORS >Zeldin DC</bp:AUTHORS>
      <bp:AUTHORS >Wegmann M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b10">
      <bp:ID >18216721</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population.</bp:TITLE>
      <bp:SOURCE >Pharmacogenet Genomics</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Zhang L</bp:AUTHORS>
      <bp:AUTHORS >Ding H</bp:AUTHORS>
      <bp:AUTHORS >Yan J</bp:AUTHORS>
      <bp:AUTHORS >Hui R</bp:AUTHORS>
      <bp:AUTHORS >Wang W</bp:AUTHORS>
      <bp:AUTHORS >Kissling GE</bp:AUTHORS>
      <bp:AUTHORS >Zeldin DC</bp:AUTHORS>
      <bp:AUTHORS >Wang DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2d">
      <bp:ID >17975109</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Larsen BT</bp:AUTHORS>
      <bp:AUTHORS >Gutterman DD</bp:AUTHORS>
      <bp:AUTHORS >Sato A</bp:AUTHORS>
      <bp:AUTHORS >Toyama K</bp:AUTHORS>
      <bp:AUTHORS >Campbell WB</bp:AUTHORS>
      <bp:AUTHORS >Zeldin DC</bp:AUTHORS>
      <bp:AUTHORS >Manthati VL</bp:AUTHORS>
      <bp:AUTHORS >Falck JR</bp:AUTHORS>
      <bp:AUTHORS >Miura H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2c">
      <bp:ID >2834948</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Novel renal arachidonate metabolites.</bp:TITLE>
      <bp:SOURCE >Am J Med Sci</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Carroll MA</bp:AUTHORS>
      <bp:AUTHORS >Schwartzman M</bp:AUTHORS>
      <bp:AUTHORS >Sacerdoti D</bp:AUTHORS>
      <bp:AUTHORS >McGiff JC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >metabolic pathway of secondary metabolites</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000147</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f90">
      <bp:ID >15748653</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epoxide hydrolases: their roles and interactions with lipid metabolism.</bp:TITLE>
      <bp:SOURCE >Prog Lipid Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Newman JW</bp:AUTHORS>
      <bp:AUTHORS >Morisseau C</bp:AUTHORS>
      <bp:AUTHORS >Hammock BD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d1b">
      <bp:ID >16179585</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Vriens J</bp:AUTHORS>
      <bp:AUTHORS >Owsianik G</bp:AUTHORS>
      <bp:AUTHORS >Fisslthaler B</bp:AUTHORS>
      <bp:AUTHORS >Suzuki M</bp:AUTHORS>
      <bp:AUTHORS >Janssens A</bp:AUTHORS>
      <bp:AUTHORS >Voets T</bp:AUTHORS>
      <bp:AUTHORS >Morisseau C</bp:AUTHORS>
      <bp:AUTHORS >Hammock BD</bp:AUTHORS>
      <bp:AUTHORS >Fleming I</bp:AUTHORS>
      <bp:AUTHORS >Busse R</bp:AUTHORS>
      <bp:AUTHORS >Nilius B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4e">
      <bp:ID >17164131</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).</bp:TITLE>
      <bp:SOURCE >Prostaglandins Other Lipid Mediat</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Inceoglu B</bp:AUTHORS>
      <bp:AUTHORS >Schmelzer KR</bp:AUTHORS>
      <bp:AUTHORS >Morisseau C</bp:AUTHORS>
      <bp:AUTHORS >Jinks SL</bp:AUTHORS>
      <bp:AUTHORS >Hammock BD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c93">
      <bp:ID >14626496</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Other Lipid Mediat</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Sacerdoti D</bp:AUTHORS>
      <bp:AUTHORS >Gatta A</bp:AUTHORS>
      <bp:AUTHORS >McGiff JC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9c">
      <bp:ID >6548162</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Biosynthesis of 5,6-dihydroxyprostaglandin E1 and F1 alpha from 5,6-dihydroxyeicosatrienoic acid by ram seminal vesicles.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1984</bp:YEAR>
      <bp:AUTHORS >Oliw EH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4f">
      <bp:ID >15180494</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of cytochrome P450 metabolites of arachidonic acid in hypertension.</bp:TITLE>
      <bp:SOURCE >Curr Drug Metab</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Sarkis A</bp:AUTHORS>
      <bp:AUTHORS >Roman RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e66">
      <bp:ID >3619897</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel pool of rat liver inositol and ethanolamine phospholipids contains epoxyeicosatrienoic acids (EETs).</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1987</bp:YEAR>
      <bp:AUTHORS >Capdevila JH</bp:AUTHORS>
      <bp:AUTHORS >Kishore V</bp:AUTHORS>
      <bp:AUTHORS >Dishman E</bp:AUTHORS>
      <bp:AUTHORS >Blair IA</bp:AUTHORS>
      <bp:AUTHORS >Falck JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >arachidonic acid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000460</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dbf">
      <bp:ID >16399376</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nomenclature for mammalian soluble glutathione transferases.</bp:TITLE>
      <bp:SOURCE >Methods Enzymol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Mannervik B</bp:AUTHORS>
      <bp:AUTHORS >Board PG</bp:AUTHORS>
      <bp:AUTHORS >Hayes JD</bp:AUTHORS>
      <bp:AUTHORS >Listowsky I</bp:AUTHORS>
      <bp:AUTHORS >Pearson WR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f0e">
      <bp:ID >18383502</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical.</bp:TITLE>
      <bp:SOURCE >Pest Manag Sci</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Morisseau C</bp:AUTHORS>
      <bp:AUTHORS >Hammock BD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cdd">
      <bp:ID >4051502</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs).</bp:TITLE>
      <bp:SOURCE >Arch Biochem Biophys</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >Spearman ME</bp:AUTHORS>
      <bp:AUTHORS >Prough RA</bp:AUTHORS>
      <bp:AUTHORS >Estabrook RW</bp:AUTHORS>
      <bp:AUTHORS >Falck JR</bp:AUTHORS>
      <bp:AUTHORS >Manna S</bp:AUTHORS>
      <bp:AUTHORS >Leibman KC</bp:AUTHORS>
      <bp:AUTHORS >Murphy RC</bp:AUTHORS>
      <bp:AUTHORS >Capdevila J</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>